Why Is BioNTech Stock Surging on Wednesday?

BioNTech SE (NASDAQ: BNTX ) stock is trading higher on Wednesday. Investors are probably reacting to Merck & Co Inc. (NYSE: MRK ) and Moderna, Inc . (NASDAQ: MRNA ) topline data from individualized cancer therapy for advanced skin cancer. At a pre-planned interim analysis, the investigational combination delivered statistically significant and clinically meaningful improvements in recurrence-free survival and distant metastasis-free survival compared to standard Keytruda alone. BioNTech’s Individualized mRNA Cancer Therapy Investors should note that BioNTech is developing Autogene cevumeran (BNT122/RO7198457), an individualized mRNA cancer immunotherapy candidate encoding patient-specific tumor neoantigens aiming to induce an immune response against the patient’s individual tumor. The mechanism of action is similar to Merck/Moderna’s melanoma therap...